Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.032 AUD | +6.67% | +14.29% | +45.45% |
Mar. 25 | Actinogen Medical Notifies of Errors on M&A Slide in Recent Presentation | MT |
Mar. 07 | Actinogen Medical Initiates Final Enrolment Phase for XanaCIDD Depression Trial; Shares Rise 3% | MT |
Sales 2024 * | 7.72M 5.03M | Sales 2025 * | 20.3M 13.22M | Capitalization | 74.6M 48.58M |
---|---|---|---|---|---|
Net income 2024 * | -16M -10.42M | Net income 2025 * | -38M -24.75M | EV / Sales 2024 * | 9.9 x |
Net Debt 2024 * | 1.89M 1.23M | Net Debt 2025 * | 53.26M 34.69M | EV / Sales 2025 * | 6.3 x |
P/E ratio 2024 * |
-4
x | P/E ratio 2025 * |
-2
x | Employees | 6 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.04% |
1 day | +6.67% | ||
1 week | +14.29% | ||
Current month | -3.03% | ||
1 month | -8.57% | ||
3 months | +52.38% | ||
6 months | +60.00% | ||
Current year | +45.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 21-03-14 | |
William Souter
DFI | Director of Finance/CFO | - | Feb. 04 |
Cheryl Townsend
CTO | Chief Tech/Sci/R&D Officer | - | 22-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Morstyn
BRD | Director/Board Member | 73 | 17-11-30 |
Geoff Brooke
FOU | Founder | 68 | 99-03-22 |
Malcolm McComas
BRD | Director/Board Member | 68 | 19-04-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.032 | +6.67% | 1,749,334 |
24-03-27 | 0.03 | +5.26% | 1,902,139 |
24-03-26 | 0.0285 | +1.79% | 1,487,637 |
24-03-25 | 0.028 | -12.50% | 2,672,013 |
24-03-22 | 0.032 | +14.29% | 2,759,496 |
Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.45% | 45.63M | |
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |